SCHEMBL29654030

SCHEMBL29654030

COC(=O)c1cc2cc(Cc3ccc(Cl)cc3C(F)(F)F)n(CCO[Si](C)(C)C(C)(C)C)c2cc1F

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
RORC P51449 5/20 0.42
MRGPRX4 Q96LA9 2/20 0.35
EIF4EBP1 Q13541 2/20 0.31
PTGES O14684 1/20 0.31
HTT P42858 3/20 0.31
LMNA P02545 2/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
TDP1 Q9NUW8 1/20 0.31
POLQ O75417 1/20 0.31
DDR1 Q08345 1/20 0.31
MAPT P10636 1/20 0.30
HTR2A P28223 1/20 0.30
SLC6A4 P31645 1/20 0.30
KCNH2 Q12809 1/20 0.30
ALDH1A1 P00352 1/20 0.30
HPGD P15428 1/20 0.30
HSD17B10 Q99714 1/20 0.30
RXFP1 Q9HBX9 1/20 0.30
MBOAT4 Q96T53 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28797832 1.00 RORC (0.42) RORCMRGPRX4EIF4EBP1PTGESHTT
SCHEMBL29654132 0.87 RORC (0.51) RORCMRGPRX4DDR1MAPT
SCHEMBL28797808 0.87 RORC (0.51) RORCMRGPRX4DDR1MAPT
SCHEMBL20635537 0.87 RORC (0.53) RORCMRGPRX4HTTLMNAPOLQ
SCHEMBL28797790 0.87 RORC (0.46) RORCMRGPRX4PTGESHTTLMNA
SCHEMBL29654248 0.87 RORC (0.46) RORCMRGPRX4PTGESHTTLMNA
SCHEMBL20635394 0.77 RORC (0.54) RORCMRGPRX4HTTPOLQHTR2A
SCHEMBL21925043 0.76 RORC (0.52) RORCMRGPRX4POLQMAPT
SCHEMBL28797802 0.76 RORC (0.44) RORCMRGPRX4PTGESSMN1; SMN2POLQ
SCHEMBL21933182 0.74 PTGER4 (0.33) ALDH1A1HPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109485595-B Hydrophilic group substituted indole formamide derivative, preparation method and medical application thereof 江苏恒瑞医药股份有限公司 2022-05-27 CN disclosed